On April 16, medical Ming Kangde is released issue manual of raise capital by floating shares publicly first, among them, collect endowment amount reachs 2.13 billion yuan from 5.7 billion yuan of shrink. On May 2, medical Ming Kangde makes public collect capital net specified number to make an appointment with 2.13 billion yuan to arrive first Zhang.
50 days cross 16 meeting, successive harden, market prise to break through one billion two hundred and fifteen million seven hundred and fifty-two thousand one hundred and ninety-two close greatly etc, ming Kangde allowing drug is in A become dazzling nova.
Nevertheless, capital arrives Zhang only a month, medical Ming Kangde used fund of the about 7 market that become collect to buy product of conduct financial transactions. On June 5, medical Ming Kangde releases announcement to say, up to announcement that day, medical Ming Kangde and its subsidiary accumulative total use unused collect capital to buy the amount of product of conduct financial transactions to be 1.499 billion yuan.
According to announcement content, up to on June 5, medical Ming Kangde and subsidiary accumulative total use unused collect capital to buy the amount of product of conduct financial transactions to be one billion four hundred and ninety-nine million nine hundred thousand yuan. Product of conduct financial transactions includes: Buy accumulate connect money fixed model structural sex deposits money (protect this model) 650 million yuan, buy interest great to public construction sex deposit secures hold period (protect this model) 588.9 million yuan, buy structural sex to deposit money (protect this model) 261 million yuan, still buy Tian Tianli except this 1 date, medium silver-colored orgnaization money, collect buy the product of conduct financial transactions such as money of treasure of abundant ready money.
" negotiable securities law " company of the 15th regulation distributes fund of stock place collect to making public, what must list fund use to use according to manual of raise capital by floating shares. What manual of change raise capital by floating shares lists fund use, must make resolution via shareholder plenary meeting. Do sth without authorization changes use and did not make those who correct, perhaps approbate without shareholder plenary meeting, do not issue publicly new, appear on the market the company also is not issued blame is publicly new.
Up to now, medical Ming Kangde does not have the announcement that has resolution about holding shareholder plenary meeting, collect capital specified number changes before this namely not seasonable also announcement.
It is in manual of raise capital by floating shares of medical Ming Kangde, medical Ming Kangde says to will use collect capital specified number to be used at medicaments safety evaluate consistency of pharmacy of central extend project, copy to evaluate center of center, research and development, compensatory circulating fund to wait for utility, complement among them circulating fund makes an appointment with 640 million yuan.
But from medicine manual of Ming Kangde raise capital by floating shares looks, its cash flows to be in very comfortable position all the time. Came 2014 inside 4 report period 2017, the cash of medical Ming Kangde and cash equivalent remaining sum are 738 million yuan respectively, 1.002 billion yuan, 2.507 billion yuan, 2.466 billion yuan.
And all the time since medical Ming Kangde is buying product of conduct financial transactions. Came 2014 between 2017, medical Ming Kangde buys amount of product of bank conduct financial transactions to be 1.383 billion yuan respectively, 779 million yuan, 1.006 billion yuan, 298 million yuan.
Have statistic of the personage inside course of study, up to on June 5, 2018, 273 stocks appear on the market resent one year, among them 107 stocks bought product of conduct financial transactions, amount of accumulative total economy amounts to seventeen billion eight hundred and forteen million seven hundred and eighty thousand yuan, among them a lot of appear on the market use like company and medical Ming Kangde occupy greatly buy product of conduct financial transactions than collect capital.
And parted in order to weigh the say medical Ming Kangde of research and development to charge of the research and development between 2017 2014 all the time it is 130 million yuan, 143 million yuan, 214 million yuan, 306 million yuan, add up to about 793 million, the scale that takes business income is ordinal for 3.13% , 2.93% , 3.5% , 3.94% .
